For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Genius Sports Limited (NYSE: GENI) closed the day trading at $10.66 down -0.84% from the previous closing price of $10.75. In other words, the price has decreased by -$0.84 from its previous closing price. On the day, 2.71 million shares were traded. GENI stock price reached its highest trading level at $10.8 during the session, while it also had its lowest trading level at $10.65.
Ratios:
For a better understanding of GENI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.39. For the most recent quarter (mrq), Quick Ratio is recorded 1.73 and its Current Ratio is at 1.73. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In the most recent recommendation for this company, Wells Fargo on November 18, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $10.
On September 12, 2025, Roth Capital started tracking the stock assigning a Buy rating and target price of $16.
On July 25, 2025, Northland Capital started tracking the stock assigning a Outperform rating and target price of $14.Northland Capital initiated its Outperform rating on July 25, 2025, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 10 ’25 when Locke Mark bought 131,608 shares for $10.40 per share.
Davison Jack bought 400,673 shares of GENI for $4,167,039 on Nov 10 ’25. On Aug 25 ’25, another insider, Bradley Kimberly Williams, who serves as the Director of the company, bought 14,999 shares for $12.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 2544734976 and an Enterprise Value of 2367119104. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.47 while its Price-to-Book (P/B) ratio in mrq is 3.58. Its current Enterprise Value per Revenue stands at 3.916 whereas that against EBITDA is -25.432.
Stock Price History:
The Beta on a monthly basis for GENI is 1.81, which has changed by 0.17743707 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, GENI has reached a high of $13.73, while it has fallen to a 52-week low of $8.15. The 50-Day Moving Average of the stock is -2.33%, while the 200-Day Moving Average is calculated to be -1.41%.
Shares Statistics:
Over the past 3-months, GENI traded about 5.75M shares per day on average, while over the past 10 days, GENI traded about 6501740 shares per day. A total of 242.82M shares are outstanding, with a floating share count of 219.42M. Insiders hold about 8.08% of the company’s shares, while institutions hold 92.73% stake in the company. Shares short for GENI as of 1764288000 were 23491727 with a Short Ratio of 4.09, compared to 1761868800 on 22354897. Therefore, it implies a Short% of Shares Outstanding of 23491727 and a Short% of Float of 10.76.
Earnings Estimates
The stock of Genius Sports Limited (GENI) is currently being evaluated by 1.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.03, with high estimates of $0.02 and low estimates of -$0.06.
Analysts are recommending an EPS of between $0.3 and $0.3 for the fiscal current year, implying an average EPS of $0.3. EPS for the following year is $0.41, with 1.0 analysts recommending between $0.41 and $0.41.
Revenue Estimates
17 analysts predict $227.03M in revenue for. The current quarter. It ranges from a high estimate of $234M to a low estimate of $225.8M. As of. The current estimate, Genius Sports Limited’s year-ago sales were $175.53MFor the next quarter, 17 analysts are estimating revenue of $173.58M. There is a high estimate of $181M for the next quarter, whereas the lowest estimate is $161.5M.
A total of 17 analysts have provided revenue estimates for GENI’s current fiscal year. The highest revenue estimate was $663.1M, while the lowest revenue estimate was $654.8M, resulting in an average revenue estimate of $656.02M. In the same quarter a year ago, actual revenue was $510.89MBased on 19 analysts’ estimates, the company’s revenue will be $780.66M in the next fiscal year. The high estimate is $835.9M and the low estimate is $729M.
